Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase

Molecular Pharmacology

Volumn 63, Issue 1, 2003, Pages 105-110

  Liou, Jieh Yuan ^a   Krishnan, Preethi ^a   Hsieh, Cheng Chih ^a   Dutschman, Ginger E ^a   Cheng, Yung chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2' FLUORO 5 METHYLARABINOFURANOSYLURACIL; BETA DEXTRO 2',3' DIDEOXYCYTIDINE; BETA LEVO 2',3' DIDEOXY 2',3' DIDEHYDRO 5 FLUOROCYTIDINE; BETA LEVO 2',3' DIDEOXY 5' FLUORO 3' THIACYTIDINE; BETA LEVO DIOXOLANECYTIDINE; DEOXYCYTIDINE PHOSPHATE DEAMINASE; DRUG METABOLITE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NUCLEOSIDE DERIVATIVE; PYRIMIDINE DERIVATIVE; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; BINDING SITE; CHIRALITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; HUMAN; HUMAN CELL; METABOLITE; PHOSPHORYLATION; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; DCMP DEAMINASE; DEAMINATION; DEOXYCYTIDINE MONOPHOSPHATE; HEPATITIS B VIRUS; HIV; HUMANS; PYRIMIDINES; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0037220313     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.1.105     Document Type: Article

References (41)

1. Abbruzzese JL, Schmidt S, Raber MN, Levy JK, Castellanos AM, Legha SS, and Krakoff IH (1989) Phase I trial of 1-(2′-deoxy-2′-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity. Investig New Drugs 7:195-201.
2. Balzarini J, Herdewijn P, and De Clercq E (1989) Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol Chem 264:6127-6133.
3. Balzarini J, Pauwels R, Baba M, Herdewijn P, de Clercq E, Broder S, and Johns DG (1988) The in vitro and in vivo anti-retrovirus activity and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol 37:897-903.
4. Bridges EG and Cheng YC (1995) Use of novel β-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma. Prog Liver Dis 13:231-245.
5. Chang CN, Doong SL, Zhou JH, Beach JW, Jeong LS, Chu CK, Tsai CH, Cheng YC, Liotta D, and Schinazi RF (1992) Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J Biol Chem 267:13938-13942.
6. Chen CH, Vazquez-Padua M, and Cheng YC (1991) Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 39:625-628.
7. Cheng YC (2001) L-Nucleoside analogues against cancer-causing viruses have potential in the prevention, delayed onset and treatment of viral associated cancers. Antivir Chem Chemother 12:S5-S11.
8. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3018.
9. Chu CK, Ma T, Shanmuganathan K, Wang C, Xiang Y, Pai SB, Yao GQ, Sommadossi JP, and Cheng YC (1995) Use of 2′-fluoro -5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob Agents Chemother 39:979-981.
10. De Clercq E (2001) New developments in anti-HIV chemotherapy. Curr Med Chem 8:1543-1572.
11. Doong SL, Tsai CH, Schinazi RF, Liotta DC, and Cheng YC (1991) Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA 88:8495-8499.
12. Ellims PH, Kao AY, and Chabner BA (1981) Deoxycytidylate deaminase. Purification and some properties of the enzyme isolated from human spleen. J Biol Chem 256:6335-6340.
13. Fourel I, Li J, Hantz O, Jacquet C, Fox JJ, and Trepo C (1992) Effects of 2′fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. J Med Virol 37:122-126.
14. Frick LW, Nelson DJ, St Clair MH, Furman PA, and Krenitsky TA (1988) Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154:124-129.
15. Fridland A, Connelly MC, and Ashmun R (1990) Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3′-azido-3′-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM). Mol Pharmacol 37:665-670.
16. Giles FJ, Cortes JE, Baker SD, Thomas DA, O'Brien S, Smith TL, Beran M, Bivins C, Jolivet J, and Kantarjian HM (2001) Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia. J Clin Oncol 19:762-771.
17. Grove KL, Guo X, Liu SH, Gao Z, Chu CK, and Cheng YC (1995) Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res 55:3008-3011.
18. Grove KL and Cheng YC (1996) Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells. Cancer Res 56:4187-4191.
19. Heinemann V, Xu YZ, Chubb S, Sen A, Hertel LW, Grindey GB, and Plunkett W (1992) Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: A mechanism of self-potentiation. Cancer Res 52:533-539.
20. Hirsch MS. AIDS commentary. (1988) Azidothymidine. J Infect Dis 157:427-431.
21. Ho HT and Hitchcock MJ (1989) Cellular pharmacology of 2′,3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob Agents Chemother 33:844-849.
22. Jamieson GP, Finch LR, Snook M, and Wiley JS (1987) Degradation of 1-beta-D-arabinofuranosylcytosine 5′-triphosphate in human leukemic myeloblasts and lymphoblasts. Cancer Res 47:3130-3135.
23. Kadhim SA, Bowlin TL, Waud WR, Angers EG, Bibeau L, DeMuys JM, Bednarski K, Cimpoia A, and Attardo G (1997) Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Cancer Res 57:4803-4810.
24. Kong XB, Scheck AC, Price RW, Vidal PM, Fanucchi MP, Watanabe KA, Fox JJ, and Chou TC (1988) Incorporation and metabolism of 2′-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells. Antiviral Res 10:153-166.
25. Krishnan P, Fu Q, Lam W, Liou JY, Dutschman G, and Cheng YC (2002) Phosphorylation of pyrimidine deoxynucleoside analog diphosphates: Selective phosphorylation of L-nucleoside analog diphosphates by 3-phosphoglycerate kinase. J Biol Chem 277:5453-5459.
26. Liou JY, Dutschman GE, Lam W, Jiang Z, and Cheng YC (2002) Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. Cancer Res 62:1624-1631.
27. Maley F and Maley GF (1960) Nucleotide interconversion. II. Elevation of deoxycytidylate deaminase and thymidylate synthetase in rat regenerating liver. J Biol Chem 235:2968-2970.
28. Maley F and Maley GF (1972) The regulatory influence of allosteric effectors on deoxycytidylate deaminases. Curr Top Cell Regul 5:177-228.
29. Maley GF, Lobo AP, and Maley F (1993) Properties of an affinity-column-purified human deoxycytidylate deaminase. Biochim Biophys Acta 1162:161-170.
30. Mancini WR and Cheng YC (1983) Human deoxycytidylate deaminase. Substrate and regulator specificities and their chemotherapeutic implications. Mol Pharmacol 23:159-164.
31. Marongiu ME, August EM, and Prusoff WH (1990) Effect of 3′-deoxythymidin-2′-ene (d4T) on nucleoside metabolism in H9 cells. Biochem Pharmacol 39:1523-1528.
32. Matthes E, Lehmann C, Scholz D, von Janta-Lipinski M, Gaertner K, Rosenthal HA, and Langen P (1987) Inhibition of HIV-associated reverse transcriptase by sugarmodified derivatives of thymidine 5′-triphosphate in comparison to cellular DNA polymerases alpha and beta. Biochem Biophys Res Commun 148:78-85.
33. Moore LE, Boudinot FD, and Chu CK (1997) Preclinical pharmacokinetics of beta-L-dioxolane-cytidine, a novel anticancer agent, in rats. Cancer Chemother Pharmacol 39:532-536.
34. Reichard P (1988) Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 57:349-374.
35. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, et al. (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 23:192-197.
36. Ruth JL and Cheng YC (1981) Nucleoside analogues with clinical potential in antivirus chemotherapy. The effect of several thymidine and 2′-deoxycytidine analogue 5′-triphosphates on purified human (α, β) and herpes simplex virus (types 1, 2) DNA polymerases. Mol Pharmacol 20:415-422.
37. Schinazi RF, Chu CK, Peck A, McMillan A, Mathis R, Cannon D, Jeong LS, Beach JW, Choi WB, Yeola S, et al. (1992) Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes. Antimicrob Agents Chemother 36:672-676.
38. Sommadossi JP, Carlisle R, and Zhou Z (1989) Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 36:9-14.
39. Surbone A, Yarchoan R, McAtee N, Blum MR, Maha M, Allain JP, Thomas RV, Mitsuya H, Lehrman SN, Leuther M, et al (1988) Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3′-azido-2′,3′-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study. Ann Intern Med 108:534-540.
40. Zhu YL, Dutschman DE, Liu SH, Bridges EG, and Cheng YC (1998) Anti-hepatitis B virus activity and metabolism of 2′,3′-dideoxy-2′,3′-didehydro-β-L(-)- 5-fluorocytidine. Antimicrob Agents Chemother 42:1805-1810.
41. Zhu Z, Hitchcock MJ, and Sommadossi JP (1991) Metabolism and DNA interaction of 2′,3′-didehydro-2′,3′-dideoxythymidine in human bone marrow cells. Mol Pharmacol 40:838-845.